Pavliv Leo 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Apr 29, 2022
Insider Transaction Report
Form 4
Pavliv Leo
Vice President, Operations
Transactions
- Award
Options (right to buy)
2022-03-16+5,000→ 5,000 totalExercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]100% vesting on March 16, 2026.